Last reviewed · How we verify
NCT06344741
Consequences of Admission to the Delivery Room in the Early and Late Phases
trial testing Accepted in latent phase in Fear of Childbirth in 248 participants. Completed in 31 July 2024.
15 July 2024
Quick facts
| Lead sponsor | Kocaeli University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 248 |
| Start date | 13 October 2023 |
| Primary completion | 15 July 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Accepted in latent phase
- Accepted in active phase
Conditions studied
- Fear of Childbirth — all drugs for Fear of Childbirth →
- Neonatal — all drugs for Neonatal →
- Pain — all drugs for Pain →
- Maternal Distress (During Labor) — all drugs for Maternal Distress (During Labor) →
Sponsor
Kocaeli University
Who can join
Adults 18 to 45, female only, with Fear of Childbirth or Neonatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be conducted to compare maternal and neonatal outcomes of pregnant women who applied to the delivery room in the early (latent) and late (active) phase. The population of the research will consist of participants who applied to Darıca Farabi Training and Research Hospital for birth. To determine the sample size of the study, first, those who meet the inclusion criteria and are admitted to the delivery room in the latent phase and those who are accepted in the active phase will be numbered and recruited sequentially. When the number of participants in the 100 latent and 100 active acceptance groups is reached, the effect size will be calculated using the STAI score averages and the G\*Power program, and the exact sample number will be determined, taking into account possible data losses. If necessary, data collection will continue until the target number is reached. Randomization will not be applied in the study. Data will be collected with the maternal and neonatal information form, State and Trait Anxiety Scale (STAI), Fear of Birth Scale, Neonatal Pain and Stress Assessment Scale (ALPS-Neo) and Visual analog scale for birth satisfaction. Data will be collected by the assistant researcher. Statistical analysis will be performed using IBM SPSS Statistic. Descriptive statistical methods will be used to evaluate socio-demographic data, and parametric/nonparametric tests will be used for comparative analyses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06344741
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fear of Childbirth
Currently open trials in the same condition.
- NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
- NCT07268027 — Constructivist Prenatal Education Effects · NA · recruiting
- NCT07263750 — Effect of Haptonomy on Prenatal Attachment and Fear of Childbirth in Primiparous Couples · NA · recruiting
- NCT06813547 — Emotional Freedom Techniques and Virtual Reality Application for Fear of Childbirth · NA · recruiting
Other Kocaeli University trials
Trials by the same sponsor.
- NCT06737887 — The Effect of Preoperative Stoma Simulation on Anxiety and Postoperative Adaptation · NA · recruiting
- NCT07483593 — Baseline Gastric Volume in Diabetic vs Non-Diabetic Patients · not yet recruiting
- NCT07536659 — Evaluation of Serum Autophagic Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Individuals · enrolling by invitation
- NCT07482696 — Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation · NA · not yet recruiting
- NCT07497945 — Optic Nerve Sheath Diameter for Predicting Post-Dural Puncture Headache in Cesarean Section Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06344741 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kocaeli University
- Last refreshed: 30 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06344741.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing